Gotowa bibliografia na temat „Biomarkers”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Biomarkers”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Biomarkers"
Mitterhauser, Markus, i Wolfgang Wadsak. "Imaging Biomarkers or Biomarker Imaging?" Pharmaceuticals 7, nr 7 (25.06.2014): 765–78. http://dx.doi.org/10.3390/ph7070765.
Pełny tekst źródłaZhao, Xuemei, Vijay Modur, Leonidas N. Carayannopoulos i Omar F. Laterza. "Biomarkers in Pharmaceutical Research". Clinical Chemistry 61, nr 11 (1.11.2015): 1343–53. http://dx.doi.org/10.1373/clinchem.2014.231712.
Pełny tekst źródłaGrandjean, P. "Biomarkers in epidemiology". Clinical Chemistry 41, nr 12 (1.12.1995): 1800–1803. http://dx.doi.org/10.1093/clinchem/41.12.1800.
Pełny tekst źródłaWishart, David S., Brendan Bartok, Eponine Oler, Kevin Y. H. Liang, Zachary Budinski, Mark Berjanskii, AnChi Guo, Xuan Cao i Michael Wilson. "MarkerDB: an online database of molecular biomarkers". Nucleic Acids Research 49, nr D1 (27.11.2020): D1259—D1267. http://dx.doi.org/10.1093/nar/gkaa1067.
Pełny tekst źródłaDe Jesus, J. R., i Marco Arruda. "Human disease biomarkers: challenges, advances, and trends in their validation". Journal of Integrated OMICS 11, nr 2 (29.12.2021): 16–28. http://dx.doi.org/10.5584/jiomics.v11i2.207.
Pełny tekst źródłaDean, Brian. "Dissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers". Schizophrenia Research and Treatment 2011 (2011): 1–10. http://dx.doi.org/10.1155/2011/614730.
Pełny tekst źródłaWeickert, Cynthia S., Thomas W. Weickert, Anil Pillai i Peter F. Buckley. "Biomarkers in Schizophrenia: A Brief Conceptual Consideration". Disease Markers 35 (2013): 3–9. http://dx.doi.org/10.1155/2013/510402.
Pełny tekst źródłaCaliff, Robert M. "Biomarker definitions and their applications". Experimental Biology and Medicine 243, nr 3 (luty 2018): 213–21. http://dx.doi.org/10.1177/1535370217750088.
Pełny tekst źródłaBirkeland, Marian L., i Joan S. McClure. "Optimizing the Clinical Utility of Biomarkers in Oncology: The NCCN Biomarkers Compendium". Archives of Pathology & Laboratory Medicine 139, nr 5 (21.10.2014): 608–11. http://dx.doi.org/10.5858/arpa.2014-0146-ra.
Pełny tekst źródłaPrentice, Ross L. "Criteria for Acceptable Dietary Intake Biomarkers". Cancer Epidemiology, Biomarkers & Prevention 31, nr 6 (1.06.2022): 1151–53. http://dx.doi.org/10.1158/1055-9965.epi-22-0180.
Pełny tekst źródłaRozprawy doktorskie na temat "Biomarkers"
Takala, H. (Heikki). "Biomarkers in esophageal cancer". Doctoral thesis, Oulun yliopisto, 2012. http://urn.fi/urn:isbn:9789514298400.
Pełny tekst źródłaTiivistelmä Solukerrosten läpäisevyyttä, verisuonten uudismuodostusta ja kasvainsolujen liikkuvuutta säätelevät tekijät voivat toimia ruokatorvisyövän ennustetekijöinä ja hoidon kohteina. Tässä tutkimuksessa selvitettiin klaudiinien, hypoksia-indusoituvan tekijän 1α (HIF-1α), verisuonen endoteelin kasvutekijän A (VEGF), kolmen typpioksidisyntaasin (iNOS, eNOS ja nNOS) sekä tollin kaltaisen reseptorin 9 (TLR9) ilmentymistä ja merkitystä ruokatorvisyövässä immunohistokemiallisin menetelmin. Tuloksia arvioitiin suhteessa proliferaatioon ja apoptoosiin. Useimmat syöpäkasvaimet ilmensivät jokaista tutkittua klaudiinia. Ruokatorven rauhassyövässä ilmeni levyepiteelisyöpää useammin klaudiineja 3 ja 5. Klaudiinin 3 vähäinen ilmentyminen oli yhteydessä etäpesäkkeiseen tautiin. Sama suuntaus näkyi klaudiinin 4 kohdalla. Apoptoosia todettiin enemmän kasvaimissa, jotka ilmensivät muita enemmän klaudiini 4:ä. Useimmat syöpäkasvaimet ilmensivät HIF-1α:a. Sekä iNOS että HIF-1α ilmentyivät runsaammin levyepiteeli- kuin rauhassyövässä. Tutkimus viittasi yhteyteen voimakkaan HIF-1α:n ilmentymisen ja VEGF:n ilmentymisen välillä. Voimakas HIF-1α:n ilmentyminen ja VEGF:n ilmentyminen vaikuttivat liittyvän ruokatorven levyepiteelisyövän uudissuonituksen lisääntymiseen. Rauhassyövän lisääntynyt uudissuonitus kasvaimen ulkopuolella saattaa liittyä VEGF:n ilmentymiseen. Potilailla, joiden kasvaimissa HIF-1α:n ilmentyminen oli voimakasta, todettiin etäpesäkkeitä muita useammin. VEGF:a ei todettu normaalissa limakalvossa, ja sen ilmentyminen vaikutti olevan yleisempää syvälle kasvavissa kuin pinnallisissa syövissä. TLR9 ilmentyi voimakkaammin levyepiteelin dysplasiassa kuin normaalissa tai kasvainepiteelissä. Huonosti erilaistuvissa ja levinneissä kasvaimissa TLR9 ilmentyi voimakkaammin kuin muissa kasvaimissa. Ruokatorvisyövän synty ja eteneminen voivat liittyä HIF:n ja VEGF:n säätelemään verisuonten uudismuodostukseen. Klaudiinit saattavat vaikuttaa syövän käyttäytymiseen myös apoptoosin ja proliferaation kautta. Tutkimuksessa todettiin yhteys lisääntyneen klaudiinin 3 ilmentymisen ja voimakkaasti ilmentyvän TLR9:n välillä. Muutos klaudiinin 3 ilmentymisessä saattaa lisätä levyepiteelin läpäisevyyttä johtaen TLR9:n aktivoitumiseen. TLR9 voi vaikuttaa ruokatorven levyepiteelin dysplasian ja syövän syntyyn sekä toimia vaikean dysplasian ja aggressiivisen levyepiteelisyövän merkkiaineena
Blyth, Alison. "Lipid biomarkers in speleothems". Thesis, University of Newcastle Upon Tyne, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.435638.
Pełny tekst źródłaScott-Fordsmand, Janeck James. "Biomarkers of soil contamination". Thesis, University of Reading, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.265176.
Pełny tekst źródłaHasan, Nazeeha. "Biomarkers for ischaemic stroke". Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/27254.
Pełny tekst źródłaAlhilal, Maryam. "Biomarkers of fat intake". Thesis, King's College London (University of London), 2013. https://kclpure.kcl.ac.uk/portal/en/theses/biomarkers-of-fat-intake(32ce2b69-77d6-4cc8-93d7-2d9c38b6f9d4).html.
Pełny tekst źródłaEsteves, Eduardo Jorge Mónica. "Biomarkers in Ovis aries". Master's thesis, Universidade de Aveiro, 2014. http://hdl.handle.net/10773/14034.
Pełny tekst źródłaFerramentas que armazenem e procedam à catalogação das proteínas identificadas em proteomas resultantes de amostras de tecidos diversos recolhidos a partir de indivíduos representativos de situações fisiológicas e patológicas, constituem instrumentos poderosos para a integração da informação já publicada. Muita informação sobre os mecanismos moleculares subjacentes a patologias pode hoje ser gerada a partir de estratégias bioinformáticas. No âmbito de projetos anteriormente desenvolvidos foi construída uma base de dados, o OralOme. O presente trabalho tem como objetivo a criação de uma base de dados, o OvinOme, aplicando a mesma metodologia desenvolvida para saúde humana, agora para o armazenamento e catalogação de proteínas identificadas a partir dos proteomas parciais de Ovis aries. A criação desta ferramenta bioinformática contribuirá para o desenvolvimento de métodos de diagnóstico em vida, capazes de detetar as principais patologias que grassam nos rebanhos de ovelhas Serra da Estrela. O desenvolvimento da base de dados passa pelo compilar manual das proteínas identificadas pelos vários estudos publicados relativamente a Ovis aries, anotando toda a informação relativa à caracterização do individuo dador da amostra, tipo de amostra biológica, técnicas utilizadas para a identificação das proteínas e toda a informação conhecida relativa a cada proteína catalogada. O desenvolvimento de um método de diagnóstico em vida passa pela concepção de protocolos de colheita, armazenamento e caracterização da qualidade da amostra. Assim no âmbito de presente trabalho foi também objectivo o desenvolvimento de toda a estratégia para recolha de amostras de saliva em ovinos, transporte, armazenamento e avaliação da qualidade da amostra. A criação de um banco de saliva de rebanhos de ovelhas Serra da Estrela será um objectivo a cumprir em termos de futuro, visando o estabelecimento do diagnóstico precoce utilizando a saliva como fluído para avaliação de proteínas que identifiquem cada patologia, determinadas por análise in silico recorrendo á ferramenta bioinformática OvinOme desenvolvida no âmbito do presente trabalho.
Tools that store and proceed to the cataloging of proteins identified in proteomes derived from samples of various tissues collected from individuals representative of physiological and pathological situations, are powerful tools for the integration of information already published. Much information about the molecular mechanisms underlying pathologies can now be generated from bioinformatic strategies. Under previously developed design was built a database, the OralOme. This work aims to create a database, the OvisOme, applying the same methodology developed for human health now for storage and cataloging of proteins identified from the partial proteomes of Ovis aries. The creation of this bioinformatics tool will contribute to the development of diagnostic methods in life, able to detect major diseases that are rife in flocks of sheep Serra da Estrela. The development database is compiled by the proteins identified by several studies published for manual Ovis aries, noting all the information on the individual characteristics of the donor of the sample, type of biological sample, techniques for identifying proteins and whole known information cataloged for each protein. The development of a method of diagnosis in living passes through the design of the harvesting, storage and characterization of the quality of the sample protocols. So within this study was also aimed at developing the whole strategy for collecting samples of saliva in sheep, transport, storage and evaluation of sample quality. The creation of a database of flocks of sheep saliva Serra da Estrela is a key objective for the future, for the establishment of early diagnosis using saliva as a fluid for evaluation of proteins that identify each pathology, determined by in silico analysis using OvisOme bioinformatics tool developed under this work.
Keane, Colm. "Novel Biomarkers in DLBCL". Thesis, Griffith University, 2015. http://hdl.handle.net/10072/365557.
Pełny tekst źródłaThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Medical Science
Griffith Health
Full Text
Andersson, Martina. "Local, intestinal biomarkers for early detection of colorectal cancer". Thesis, Uppsala universitet, Institutionen för farmaci, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-445701.
Pełny tekst źródłaKant, Prashant. "Changes in biomarkers of colorectal cancer risk and biomarkers of inflammation following weight loss". Thesis, University of Leeds, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.590418.
Pełny tekst źródłaLiu, Faye Fang. "Biomarkers for chronic arsenic poisoning /". [St. Lucia, Qld.], 2004. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18519.pdf.
Pełny tekst źródłaKsiążki na temat "Biomarkers"
Peakall, David B., i Lee R. Shugart, red. Biomarkers. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-84631-1.
Pełny tekst źródłaEvans, Williams. Biomarkers. New York: S & S, 1991.
Znajdź pełny tekst źródłaDeep, Gagan, red. Cancer Biomarkers. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-1896-7.
Pełny tekst źródłaMartí-Bonmatí, Luis, i Angel Alberich-Bayarri, red. Imaging Biomarkers. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-43504-6.
Pełny tekst źródłaMorrow, David A., red. Cardiovascular Biomarkers. Totowa, NJ: Humana Press, 2006. http://dx.doi.org/10.1007/978-1-59745-051-5.
Pełny tekst źródłaPeplow, Philip V., Bridget Martinez i Svetlana A. Dambinova, red. Stroke Biomarkers. New York, NY: Springer New York, 2020. http://dx.doi.org/10.1007/978-1-4939-9682-7.
Pełny tekst źródłaMaisel, Alan S., i Allan S. Jaffe, red. Cardiac Biomarkers. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-42982-3.
Pełny tekst źródłaSalvi, Samanta, i Valentina Casadio, red. Urinary Biomarkers. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1354-2.
Pełny tekst źródłaNass, Sharyl J., i Harold L. Moses, red. Cancer Biomarkers. Washington, D.C.: National Academies Press, 2007. http://dx.doi.org/10.17226/11892.
Pełny tekst źródła1927-, Yen Teh Fu, i Moldowan J. M. 1946-, red. Geochemical biomarkers. Chur: Harwood Academic Publishers, 1988.
Znajdź pełny tekst źródłaCzęści książek na temat "Biomarkers"
Chaubey, Vikas P., Kevin B. Laupland, Christopher B. Colwell, Gina Soriya, Shelden Magder, Jonathan Ball, Jennifer M. DiCocco i in. "Biomarkers". W Encyclopedia of Intensive Care Medicine, 317. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_3038.
Pełny tekst źródłaMocellin, Simone. "Biomarkers". W Soft Tissue Tumors, 25–26. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-58710-9_5.
Pełny tekst źródłaHarbron, Chris. "Biomarkers". W Nonclinical Statistics for Pharmaceutical and Biotechnology Industries, 365–80. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-23558-5_14.
Pełny tekst źródłaShetty, Vivek. "Biomarkers". W Encyclopedia of Behavioral Medicine, 257–59. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_232.
Pełny tekst źródłaWideman, Timothy H., Michael J. L. Sullivan, Shuji Inada, David McIntyre, Masayoshi Kumagai, Naoya Yahagi, J. Rick Turner i in. "Biomarkers". W Encyclopedia of Behavioral Medicine, 225–27. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_232.
Pełny tekst źródłaDebnath, Mousumi, Godavarthi B. K. S. Prasad i Prakash S. Bisen. "Biomarkers". W Molecular Diagnostics: Promises and Possibilities, 287–308. Dordrecht: Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-3261-4_18.
Pełny tekst źródłaMose, Stephan, Stephan Mose, Brandon J. Fisher, Iris Rusu, Charlie Ma, Lu Wang, Larry C. Daugherty i in. "Biomarkers". W Encyclopedia of Radiation Oncology, 28. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-540-85516-3_605.
Pełny tekst źródłaJavaux, Emmanuelle J. "Biomarkers". W Encyclopedia of Astrobiology, 293. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-44185-5_180.
Pełny tekst źródłaDevasena T. "Biomarkers". W Therapeutic and Diagnostic Nanomaterials, 29–40. Singapore: Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-0923-5_3.
Pełny tekst źródłaWeir, David. "Biomarkers". W The Palgrave Handbook of Survey Research, 573–86. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-54395-6_65.
Pełny tekst źródłaStreszczenia konferencji na temat "Biomarkers"
Nogueira, Cristiana Bello Dultra, João Gustavo dos Anjos Morais Oliveira i Alexandre Martins Lopes Filho. "The use of biomarkers in Duchenne muscular dystrophy – a literature review". W XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.330.
Pełny tekst źródłaBrum, Wagner, Andrei Bieger, Joao Pedro Ferrari Souza, Marco de Bastiani, Andrea Benedet, Nicholas Ashton, Tharick Pascoal i in. "A THREE-RANGE APPROACH ENHANCES PROGNOSTIC UTILITY OF CSF BIOMARKERS IN ALZHEIMER’S DISEASE". W XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda022.
Pełny tekst źródłaCorrie, Simon R., Jacob W. Coffey i Mark A. F. Kendall. "In Vivo Biomarker Capture via the Skin Using Surface-Modified Microprojection Arrays". W ASME 2013 2nd Global Congress on NanoEngineering for Medicine and Biology. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/nemb2013-93215.
Pełny tekst źródłaKallingal, Nithusha, Kishor Kumar Sadasivuni, Issam Bahadur, Huseyin Cagatay Yalcin, Asiya Al-Busaidi, Hassen M. Ouakad i Somaya Al-Maadeed. "Colorimetry-based Detection of Exhaled Breath Biomarkers for Predicting Heart Failure". W Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0077.
Pełny tekst źródłaSathija, P. K., S. Rajaram, V. K. Arora, B. Gupta i N. Goel. "Evaluation of biomarkers p16ink4a/ki-67 in cervical cytology for diagnosis of cervical intraepithelial neoplasia". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685267.
Pełny tekst źródłaWu, Liangliang, Xinyan Fang, Bin Cheng i Ansong Geng. "Occluded Biomarkers or Covalently Bound Biomarkers?" W 29th International Meeting on Organic Geochemistry. European Association of Geoscientists & Engineers, 2019. http://dx.doi.org/10.3997/2214-4609.201902695.
Pełny tekst źródłaCollins, Hannah, Rahul Pal, Murali Krishnamoorthy, Thinzar Lwin, Eben L. Rosenthal, Patrick Wagner i Anand T. N. Kumar. "Fluorescence Lifetime (FLT)-Enhanced Tumor Imaging with Biomarker-Targeted Agents". W Clinical and Translational Biophotonics. Washington, D.C.: Optica Publishing Group, 2024. http://dx.doi.org/10.1364/translational.2024.ts5b.2.
Pełny tekst źródłaWadduwage, Dushan N. "Stochastic Proof by Contradiction Complements Machine-learning-driven Biomarker Discovery in Image Data". W Clinical and Translational Biophotonics. Washington, D.C.: Optica Publishing Group, 2024. http://dx.doi.org/10.1364/translational.2024.jm4a.55.
Pełny tekst źródłaGoncharov, Artem, Hyou-Arm Joung, Rajesh Ghosh, Gyeo-Re Han, Zachary S. Ballard, Quinn Maloney, Alexandra Bell i in. "Fluorescence-based multiplexed point-of-care sensor using deep learning". W Bio-Optics: Design and Application. Washington, D.C.: Optica Publishing Group, 2023. http://dx.doi.org/10.1364/boda.2023.dtu3a.7.
Pełny tekst źródłaBurenkov, I. A., J. Sabines-Chesterking i S. V. Polyakov. "Resolving Single Molecules in Flow Cytometer in Presence of Fluorescent Bursts via an Optical Quantum Measurement". W CLEO: Applications and Technology. Washington, D.C.: Optica Publishing Group, 2023. http://dx.doi.org/10.1364/cleo_at.2023.jth2a.37.
Pełny tekst źródłaRaporty organizacyjne na temat "Biomarkers"
Atherosclerosis Biomarkers by Computed Tomography Angiography (CTA). Chair Andrew Buckler, Luca Saba i Uwe Joseph Schoepf. Radiological Society of North America (RSNA) / Quantitative Imaging Biomarkers Alliance (QIBA), marzec 2023. http://dx.doi.org/10.1148/qiba/20230328.
Pełny tekst źródłaSaba, Luca, i Uwe Joseph Schoepf. Atherosclerosis Biomarkers by Computed Tomography Angiography (CTA) - Maintenance version June 2024. Chair Andrew Buckler. Radiological Society of North America (RSNA) / Quantitative Imaging Biomarkers Alliance (QIBA), czerwiec 2024. http://dx.doi.org/10.1148/qiba/202406.
Pełny tekst źródłaMarmar, Charles R. Biomarkers for PTSD. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2010. http://dx.doi.org/10.21236/ada618637.
Pełny tekst źródłaMarmar, Charles. Biomarkers for PTSD. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2011. http://dx.doi.org/10.21236/ada618638.
Pełny tekst źródłaMarmar, Charles R. Biomarkers for PTSD. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2012. http://dx.doi.org/10.21236/ada619951.
Pełny tekst źródłaZhu, Mucheng, Zhenhua Lu, Hao Guo, Xiaoting Gu, Defang Wei i Zhengyi Zhang. Diagnostic Value of Combination of Biomarkers for Malignant Pleural Mesothelioma:Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, październik 2022. http://dx.doi.org/10.37766/inplasy2022.10.0043.
Pełny tekst źródłaMarmar, Charles R. Validating Biomarkers for PTSD. Fort Belvoir, VA: Defense Technical Information Center, kwiecień 2015. http://dx.doi.org/10.21236/ada620325.
Pełny tekst źródłaIrwin, Courtney L., Patrícia S. Coelho, Bruno Kluwe-Schiavon, Anabela Silva-Fernandes, Óscar F. Gonçalves, Jorge Leite i Sandra Carvalho. Treatment-related changes of molecular biomarkers in major depressive disorder: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, październik 2021. http://dx.doi.org/10.37766/inplasy2021.10.0105.
Pełny tekst źródłaZelikoff, Judith T. Fish Immune Response as Biomarkers. Fort Belvoir, VA: Defense Technical Information Center, marzec 2001. http://dx.doi.org/10.21236/ada399403.
Pełny tekst źródłaBearman, Gregory H., Darryl J. Bornhop i Richard M. Levenson. Biomarkers and Biological Spectral Imaging. Fort Belvoir, VA: Defense Technical Information Center, styczeń 2001. http://dx.doi.org/10.21236/ada409182.
Pełny tekst źródła